TORONTO, July 05, 2018 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE)
(“WeedMD” or the “Company) is pleased to announce it has entered into an agreement with the
Alberta Gaming, Liquor & Cannabis Commission (“AGLC”) to supply the province with high-quality, branded cannabis
products for sale in Alberta’s adult-use market.
“We’re proud that the AGLC has selected WeedMD as a cannabis supplier to join its network as it looks to
establish a cannabis framework for its adult-use markets,” said Keith Merker, Chief Financial Officer of WeedMD. “This represents a
strategic partnership as we look to expand our product reach across the country to support Canada’s legal adult-use market.
Alberta’s high standards align with the highly-regarded quality of our cultivation standards, product portfolio, and commercial
practices as we look to meet the expected demand of this new market.”
WeedMD will supply the Alberta market with cannabis products starting the first day of legal sales. This
agreement represents a key milestone in WeedMD’s strategic plan to develop a national distribution platform for the Company’s
medical and adult-use products, building upon the recent announcement of WeedMD’s supply agreement with Shoppers Drug
Mart1. WeedMD is actively working with provincial distributors, regulators, and retailers to expand its adult-use
distribution program, particularly as the Company completes the final stages of its 220,000 sq. ft. greenhouse retrofit within its
610,000 sq. ft. greenhouse facilty in Strathroy, Ontario.
For more information, access our investor presentation here and corporate video here.
1 Pending Health Canada approval
About WeedMD Inc.
WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer and
distributor of medical cannabis and oils under the ACMPR. The Company operates a 26,000 sq. ft. indoor facility in Aylmer, Ontario,
and a second cultivation site at its greenhouse facility located in Strathroy, Ontario, representing 610,000 sq. ft. or 14 acres
under glass. WeedMD has entered into supply agreements in addition to strategic relationships with established cannabis brands.
WeedMD is focused on providing medical cannabis to the seniors' markets in Canada through its proprietary seniors care program. It
is dedicated to educating healthcare practitioners and furthering public understanding of the role that medical cannabis plays –
including as it pertains to regulatory requirements, indications and potential side effects.
Follow WeedMD On:
Facebook: https://www.facebook.com/weedmd/
LinkedIn: https://www.linkedin.com/company-beta/5020743/
Twitter: https://twitter.com/WeedMD
Instagram: https://www.instagram.com/weedmd/
For further information, please contact:
WeedMD Inc.
Keith Merker, Chief Financial Officer
Tel: 519-765-2440 Ext. 222
Email: investor@weedmd.com
To learn more, visit us at www.weedmd.com
For Media Inquiries:
Marianella delaBarrera
Margin Communications & Public Relations
Tel: 416-897-6644
Email: marianella@marginpr.com
Forward Looking Information
This press release contains "forward-looking information" within the meaning of applicable Canadian
securities legislation which are based upon WeedMD's current internal expectations, estimates, projections, assumptions and beliefs
and views of future events. Forward-looking information can be identified by the use of forward-looking terminology such as
"expect", "likely", "may", "will", "should", "intend", "anticipate", "potential", "proposed", "estimate" and other similar words,
including negative and grammatical variations thereof, or statements that certain events or conditions "may", "would" or "will"
happen, or by discussions of strategy.
The forward-looking information in this news release is based upon the expectations, estimates, projections,
assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information
includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not
statements of fact. Forward-looking information in this news release include, but are not limited to, statements with
respect to internal expectations, expectations with respect to actual production volumes, expectations for future growing capacity
and the completion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks,
including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; future
legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or
inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of
WeedMD to implement its business strategies; competition; crop failure; and other risks.
Any forward-looking information speaks only as of the date on which it is made, and, except as required by
law, WeedMD does not undertake any obligation to update or revise any forward-looking information, whether as a result of new
information, future events or otherwise. New factors emerge from time to time, and it is not possible for WeedMD to predict all
such factors. When considering this forward-looking information, readers should keep in mind the risk factors and other cautionary
statements in WeedMD's Annual Information Form dated December 13, 2017 (the "AIF") and other disclosure documents of WeedMD filed
with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the AIF and other
disclosure documents could cause actual events or results to differ materially from those described in any forward-looking
information.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE
POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE